Lack of pretreatment cost-effectiveness and side effects of omalizumab versus prednisone/montelukast on tolerability of immunotherapy

✍ Scribed by Rosenberg, J. Loren

• Book ID: 119284084
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 41 KB
• Volume: 127
• Category: Article
• ISSN: 1097-6825
• DOI: 10.1016/j.jaci.2010.10.055